Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

main

practices-cm-57th-annual-institute-on-securities-regulation

Join Goodwin partner Dave Lynn's panel The Past and Future of Crypto Law at the 57th Annual Institute on Securities Regulation.

57th Annual Institute on Securities Regulation

Summary

Speakers

David M. Lynn

Related Content

CFPB Narrows Small Business Lending Rule

SEC Proposes Amendments to Permit Optional Semiannual Reporting by Public Companies

CFPB Finalizes Rule to Scale Back ECOA Protections

Nasdaq Adopts Enhanced SPAC IPO Listing Standards Under Both Global Market and Capital Market Tiers

SEC Staff Shortens Minimum Tender Offer Period for Certain All-Cash Offerings to 10 Business Days

Revisiting Regulation S-K: Key Themes of Public Comments

OCC and FDIC Issue Final Rule Prohibiting Use of Reputation Risk in Supervisory Frameworks

SEC Announces Enforcement Results for 2025

Getting Ahead of What’s Next: What Today’s Regulation, Disclosure Trends, and AI Mean for Public Companies

Goodwin Advises Seaport Therapeutics on Pricing of $254.9 Million Upsized Initial Public Offering

Paul Rosie Joins Goodwin’s Life Sciences Group in Boston

Capital Markets Team Guides Underwriting Syndicate on Hemab Therapeutics’ $346.7 Million Upsized Initial Public Offering

Global Capital Markets & the U.S. Securities Laws 2026

The Banks Jefferies, Leerink Partners, Evercore ISI, and Oddo BHF SCA Were Advised by Goodwin in Connection With the €48 Million Private Placement Carried Out by Medincell SA

Investors Are Suing over Proxy Proposals — Here’s What to Know (FT Agenda)

Legal 500 EMEA 2026 Recognizes Goodwin for Excellence in France, Germany, and Luxembourg

Capital Markets